Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome
Objective. To determine adipokines levels in patients with different etiologic subtypes of acute ischemic stroke (AIS) and metabolic syndrome (MetS) status. Methods. Serum adiponectin, leptin, and resistin levels were determined by ELISA in 99 AIS patients and 59 stroke-free control group subjects....
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2017/7503763 |
id |
doaj-c503260a8dcd4e27933818e70e73316a |
---|---|
record_format |
Article |
spelling |
doaj-c503260a8dcd4e27933818e70e73316a2020-11-24T23:48:40ZengHindawi LimitedInternational Journal of Endocrinology1687-83371687-83452017-01-01201710.1155/2017/75037637503763Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic SyndromeAnna Szczepańska-Szerej0Jacek Kurzepa1Aneta Grabarska2Joanna Bielewicz3Ewa Wlizło-Dyś4Konrad Rejdak5Department of Neurology, Medical University of Lublin, Lublin, PolandDepartment of Medical Chemistry, Medical University of Lublin, Lublin, PolandDepartment of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, PolandDepartment of Neurology, Medical University of Lublin, Lublin, PolandDepartment of Neurology, Medical University of Lublin, Lublin, PolandDepartment of Neurology, Medical University of Lublin, Lublin, PolandObjective. To determine adipokines levels in patients with different etiologic subtypes of acute ischemic stroke (AIS) and metabolic syndrome (MetS) status. Methods. Serum adiponectin, leptin, and resistin levels were determined by ELISA in 99 AIS patients and 59 stroke-free control group subjects. Stroke patients were grouped based on MetS, modified TOAST classification, and CHA2DS2-VASc scale in case of cardioembolic stroke following atrial fibrillation. Results. No differences were found in all adipokine serum levels between AIS patients and appropriately matched control group. MetS-AIS patients had significantly higher leptin levels (22.71 ± 19.01 ng/ml versus 8.95 ± 9.22 ng/ml, p<0.001) and lower adiponectin levels (10.71 ± 8.59 ng/ml versus 14.93 ± 10.95 ng/ml, p<0.05) than non-MetS-AIS patients. In patients with cardioembolic stroke, leptin levels were significantly higher than in remaining stroke cases (19.57 ± 20.53 ng/ml versus 13.17 ± 12.36 ng/ml, p<0.05) and CHA2DS2-VASc score positively correlated with leptin levels only (p<0.001). Analysis of individual components of CHA2DS2-VASc score showed that hypertension, female gender, and diabetes had greatest impact on elevated serum leptin level. Conclusion. This pilot study revealed that leptin could be a potential biomarker for risk stratification of cardioembolic stroke in MetS patients and that heterogeneity of stroke subtypes should be considered for more refined and precise clinical stroke studies.http://dx.doi.org/10.1155/2017/7503763 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anna Szczepańska-Szerej Jacek Kurzepa Aneta Grabarska Joanna Bielewicz Ewa Wlizło-Dyś Konrad Rejdak |
spellingShingle |
Anna Szczepańska-Szerej Jacek Kurzepa Aneta Grabarska Joanna Bielewicz Ewa Wlizło-Dyś Konrad Rejdak Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome International Journal of Endocrinology |
author_facet |
Anna Szczepańska-Szerej Jacek Kurzepa Aneta Grabarska Joanna Bielewicz Ewa Wlizło-Dyś Konrad Rejdak |
author_sort |
Anna Szczepańska-Szerej |
title |
Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome |
title_short |
Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome |
title_full |
Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome |
title_fullStr |
Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome |
title_full_unstemmed |
Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome |
title_sort |
correlation between ch2ds2-vasc score and serum leptin levels in cardioembolic stroke patients: the impact of metabolic syndrome |
publisher |
Hindawi Limited |
series |
International Journal of Endocrinology |
issn |
1687-8337 1687-8345 |
publishDate |
2017-01-01 |
description |
Objective. To determine adipokines levels in patients with different etiologic subtypes of acute ischemic stroke (AIS) and metabolic syndrome (MetS) status. Methods. Serum adiponectin, leptin, and resistin levels were determined by ELISA in 99 AIS patients and 59 stroke-free control group subjects. Stroke patients were grouped based on MetS, modified TOAST classification, and CHA2DS2-VASc scale in case of cardioembolic stroke following atrial fibrillation. Results. No differences were found in all adipokine serum levels between AIS patients and appropriately matched control group. MetS-AIS patients had significantly higher leptin levels (22.71 ± 19.01 ng/ml versus 8.95 ± 9.22 ng/ml, p<0.001) and lower adiponectin levels (10.71 ± 8.59 ng/ml versus 14.93 ± 10.95 ng/ml, p<0.05) than non-MetS-AIS patients. In patients with cardioembolic stroke, leptin levels were significantly higher than in remaining stroke cases (19.57 ± 20.53 ng/ml versus 13.17 ± 12.36 ng/ml, p<0.05) and CHA2DS2-VASc score positively correlated with leptin levels only (p<0.001). Analysis of individual components of CHA2DS2-VASc score showed that hypertension, female gender, and diabetes had greatest impact on elevated serum leptin level. Conclusion. This pilot study revealed that leptin could be a potential biomarker for risk stratification of cardioembolic stroke in MetS patients and that heterogeneity of stroke subtypes should be considered for more refined and precise clinical stroke studies. |
url |
http://dx.doi.org/10.1155/2017/7503763 |
work_keys_str_mv |
AT annaszczepanskaszerej correlationbetweench2ds2vascscoreandserumleptinlevelsincardioembolicstrokepatientstheimpactofmetabolicsyndrome AT jacekkurzepa correlationbetweench2ds2vascscoreandserumleptinlevelsincardioembolicstrokepatientstheimpactofmetabolicsyndrome AT anetagrabarska correlationbetweench2ds2vascscoreandserumleptinlevelsincardioembolicstrokepatientstheimpactofmetabolicsyndrome AT joannabielewicz correlationbetweench2ds2vascscoreandserumleptinlevelsincardioembolicstrokepatientstheimpactofmetabolicsyndrome AT ewawlizłodys correlationbetweench2ds2vascscoreandserumleptinlevelsincardioembolicstrokepatientstheimpactofmetabolicsyndrome AT konradrejdak correlationbetweench2ds2vascscoreandserumleptinlevelsincardioembolicstrokepatientstheimpactofmetabolicsyndrome |
_version_ |
1725485237671034880 |